Lowering of blood pressure has been observed in subjects with type 2 diabetes receiving long-term treatment with GLP-1 receptor (GLP-1R) agonists, although the mechanisms underlying this are not fully understood [7]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.